Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review.
Laura DrikiteJonathan P BedfordLiam O'BryanTatjana PetrinicKim RajappanJames DoidgeDavid A HarrisonKathryn M RowanPaul R MounceyDuncan YoungPeter J WatkinsonMark CorbettPublished in: Critical care (London, England) (2021)
From the limited evidence available beta blockers or amiodarone may be superior to CCBs as first line therapy in undifferentiated patients in ICU. The little evidence available does not support therapeutic anticoagulation for NOAF whilst patients are critically ill. Consensus definitions for NOAF, rate and rhythm control are needed.
Keyphrases
- intensive care unit
- atrial fibrillation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- heart failure
- mesenchymal stem cells
- mechanical ventilation
- heart rate
- patient reported
- left atrial
- oral anticoagulants
- catheter ablation
- cell therapy
- left atrial appendage